Midbrain organoids for automated chemical screening and disease research
Max Planck Innovation licenses process for the generation of organ-like tissue aggregates to biotech company StemoniX
05-Nov-2020 -
Sometimes hundreds of thousands of potential therapeutics need to be tested in large-scale, fully automated experiments to identify a single effective drug. Most compounds do not work as desired, and some are even toxic. Since the development of the induced Pluripotent Stem (iPS) Cell technology ...
drug development
drug discovery
induced pluripotent stem cells
+1